Gene Polymorphism Might Influence Cinacalcet Response
A recent findings, if validated, may partly explain inter-individual differences in the response to cinacalcet treatment for secondary hyperparathyroidism.
All articles by Natasha Persaud
High-Dose IV Iron Reduces Myocardial Infarction in Hemodialysis
Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis.
Mixing Patiromer With Juices Does Not Impair Potassium-Binding Capacity
The FDA already approved apple or cranberry juice as alternatives for suspension.
Steroid Reduces the Risk for Major Adverse Kidney Events in IgA Nephropathy
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
Polypharmacy May Increase Risks for Kidney Failure, Cardiovascular Events
Avoiding unnecessary medications in CKD might reduce the risks for adverse outcomes, investigators suggested.
Sodium Polystyrene Sulfonate Ups Risk for Fatal Gastrointestinal Injury in HD
New data from DOPPS support previous studies finding higher risk for gastrointestinal injury after use of sodium polystyrene sulfonate.
RCT Data Needed on Phosphate-Lowering Agents and NDD-CKD Outcomes
Systematic reviews on this topic have largely been focused on patients receiving dialysis.
Promising Developments That May Improve Lupus Nephritis Management
Recent approval of new drugs for lupus nephritis and promising therapies on the horizon bode well for the care of patients with the kidney disorder.
Belimumab May Help Preserve Kidney Function in Lupus Nephritis
The risk of lupus nephritis flares decreased with belimumab treatment, investigators reported.
Phosphate Binder Dissatisfaction May Affect Patient Outcomes
Dissatisfaction with taking phosphate binders may influence medication adherence and ultimately clinical outcomes, according to investigators.
